...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Successful transplantation of kidneys from deceased donors with acute renal failure: Three-year results.
【24h】

Successful transplantation of kidneys from deceased donors with acute renal failure: Three-year results.

机译:成功地从死者的肾脏移植成功并患有急性肾功能衰竭:三年结果。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Kidneys from deceased donors with acute renal failure (ARF) are generally not accepted for transplantation because of the expected poor outcome. This prospective study examined the utilization of kidneys from donors with ARF for transplantation and the outcomes. METHODS: Fifty-five kidneys from donors with ARF were transplanted. The outcome was compared with concurrent and matched 55 recipients of standard criteria donor (SCD) kidneys and 55 expanded criteria donor (ECD) kidneys. ARF kidneys were accepted from donors aged <50 years, a negative history for kidney disease, and a negative pretransplant biopsy for chronic structural changes. The immunosuppression was similar in all three groups. The outcome measurements included three-year patient and graft survival, biopsy-proven acute rejection (BPAR), subclinical acute rejection (SCAR), and chronic allograft nephropathy (CAN), serum creatinine, and creatinine clearance. RESULTS: Three-year patient and graft survival was 90% and 90% in ARF group, 100% and 89% in SCD group and 83% and 66% in ECD group. BPAR and SCAR were comparable in the groups but CAN was significantly higher in ECD group. Mean serum creatinine levels were 1.9+/-1.1, 1.9+/-0.9, and 2.2+/-1.3 mg/dl and mean creatinine clearances were 66+/-15, 68+/-14, and 58+/-10 mls/minute in ARF, SCD, and ECD groups, respectively (SCD and ARF vs. ECD P = 0.04). CONCLUSIONS: Transplantation of kidneys from selected deceased donors with ARF provides comparable survival and function compared to kidneys from non-ARF donors and may be considered for transplantation to expand the donor pool to overcome the current acute shortage of kidneys.
机译:背景:由于预期的不良结果,通常不接受来自死者的急性肾衰竭(ARF)供者的肾脏移植。这项前瞻性研究检查了ARF供体肾脏移植的利用情况和结果。方法:从ARF供体中移植55只肾脏。将结果与并发的和匹配的55名标准标准供体(SCD)肾脏和55名扩展标准供体(ECD)肾脏进行比较。年龄小于50岁的供者接受ARF肾脏,肾脏疾病史阴性,而慢性结构改变的移植前活检阴性。在所有三个组中,免疫抑制相似。结果测量包括三年患者和移植物存活,活检证实的急性排斥反应(BPAR),亚临床急性排斥反应(SCAR)和慢性同种异体肾病(CAN),血清肌酐和肌酐清除率。结果:ARF组的三年患者和移植物存活率为90%和90%,SCD组为100%和89%,ECD组为83%和66%。 BPAR和SCAR在各组中具有可比性,但ECD组中的CAN显着更高。平均血清肌酐水平为1.9 +/- 1.1、1.9 +/- 0.9和2.2 +/- 1.3 mg / dl,平均肌酐清除率分别为66 +/- 15、68 +/- 14和58 +/- 10 mls /分钟分别在ARF,SCD和ECD组中(SCD和ARF与ECD P = 0.04)。结论:与非ARF供体的肾脏相比,从选定的已故供体的肾脏移植提供了相当的存活率和功能,可以考虑进行移植以扩大供体库以克服当前肾脏的严重短缺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号